The Poliwogg Type 2 Diabetes Index

A Disease-Specific Index

The Poliwogg Type 2 Diabetes Index represents the average healthcare costs of an American with Type 2 Diabetes for the preceding twelve months:

  • Primary source data is paid claims data from a major health insurance group
  • Index population is greater than 1.5 million individuals
  • Index is strictly rules-based
  • Base criteria for inclusion:
    – All individuals with an ICD-9 or ICD-10 diagnosis code in paid claims consistent with a diagnosis of Type 2 Diabetes
    – Continuous enrollment in a qualifying health plan during the preceding twelve months from the date being recorded
  • Frequency of publication: monthly, with data 60 days in arrears (i.e., index for the 12-month period ended April 30 is published at the beginning of July)
  • Historic data available: six years, beginning January 1, 2011 at
  • Data Reported (average cost per individual meeting the inclusion criteria):
    – Total healthcare costs for Type 2 Diabetes
    – Direct diabetes costs, Type 2 Diabetes
  • Independent calculation agent: Indxx, LLC.
  • The Poliwogg Type 2 Diabetes Index is available for license

The Poliwogg Type 2 Diabetes Index Current & Historical Prices

To receive the PWTD back-test, please send us your contact information:

Powered by ChronoForms -

Healthcare and Diabetes Facts

  • National Health Expenditure was $3.0 trillion in 2014 and accounted for 17.5% of the United States gross domestic product (GDP)1
  • 27.9 million Americans have Type 2 Diabetes; 86 million Americans have prediabetes2
  • The average medical expenditures among people with diagnosed diabetes were 2.3 times higher than what expenditures would be in the absence of diabetes3
  • The total costs of diagnosed diabetes in 2012 was $245 billion, which increased 41% over the 2007-2012-time period ($174 billion in 2007)3
  • More than $1 in every $10 healthcare dollars is attributed to diabetes3
  • Type 2 diabetes has an active new drug pipeline. Globally, there are 761 active programs being completed by 245 companies, of which 145 of these companies are based in the United States4
  • In 2012, diabetes treatment cost MORE than all the oil consumed in the United States in 2015.2,5 Oil has a suite of financial tools, futures and options, diabetes and healthcare have none.


1 "National Health Expenditure Fact Sheet." Centers for Medicare and Medicaid Services. Web. 30 Nov. 16:

2 "Statistics About Diabetes." American Diabetes Association. Web. 30 Nov. 2016:

3 "Economic Costs of Diabetes in the U.S. in 2012." American Diabetes Association. Web. 30 Nov 2016:

4 "Programs in Type 2 Diabetes." BioPharm Insight. Web. 30 Nov 16:

5 U.S. Energy Information Administration; March 17, 2016:

Poliwogg In the News